ruboxistaurin topical (DBI-102)
/ DermBiont
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 19, 2024
Randomized Study Using SM-030 Gel for Adults With Melasma
(clinicaltrials.gov)
- P2 | N=138 | Recruiting | Sponsor: DermBiont, Inc. | Trial completion date: Jul 2025 ➔ Oct 2025 | Trial primary completion date: Jan 2025 ➔ Apr 2025
Trial completion date • Trial primary completion date • Dermatology • Dermatopathology
June 12, 2024
A Randomized, Observer-Blinded, Placebo-Controlled Study on Safety and Efficacy of SM-030 in Adults With Melasma
(clinicaltrials.gov)
- P2 | N=138 | Recruiting | Sponsor: DermBiont, Inc.
New P2 trial • Dermatology • Dermatopathology
October 25, 2023
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
(clinicaltrials.gov)
- P2 | N=75 | Completed | Sponsor: DermBiont, Inc. | Recruiting ➔ Completed
Trial completion
August 23, 2022
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
(clinicaltrials.gov)
- P2 | N=75 | Recruiting | Sponsor: DermBiont, Inc.
New P2 trial
1 to 4
Of
4
Go to page
1